Imperva, Inc. (NASDAQ:IMPV) saw unusually large options trading on Tuesday. Stock investors purchased 521 put options on the company. This represents an increase of approximately Infinity compared to the average volume of 0 put options.

Several research firms have recently weighed in on IMPV. Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $55.00 target price on shares of Imperva in a research report on Thursday, November 9th. KeyCorp restated a “hold” rating on shares of Imperva in a research report on Tuesday, October 24th. Evercore ISI restated a “buy” rating and issued a $56.00 target price on shares of Imperva in a research report on Wednesday, November 8th. BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Finally, Imperial Capital decreased their target price on Imperva from $57.00 to $50.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 10th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $52.38.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at $4,341,476.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.90% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Van ECK Associates Corp grew its stake in shares of Imperva by 0.8% in the second quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock valued at $399,000 after buying an additional 64 shares in the last quarter. Comerica Bank grew its stake in Imperva by 0.8% during the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock worth $978,000 after purchasing an additional 157 shares in the last quarter. Ameritas Investment Partners Inc. grew its stake in Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after purchasing an additional 464 shares in the last quarter. Aperio Group LLC grew its stake in Imperva by 8.1% during the 2nd quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock worth $340,000 after purchasing an additional 531 shares in the last quarter. Finally, Parametric Portfolio Associates LLC grew its stake in Imperva by 5.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock worth $556,000 after purchasing an additional 581 shares in the last quarter. 98.33% of the stock is owned by institutional investors and hedge funds.

Shares of Imperva (NASDAQ IMPV) opened at $40.80 on Friday. Imperva has a one year low of $35.45 and a one year high of $52.40.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The business had revenue of $83.89 million during the quarter, compared to analysts’ expectations of $83.79 million. During the same period in the previous year, the firm posted $0.08 earnings per share. The company’s revenue was up 22.6% on a year-over-year basis. sell-side analysts expect that Imperva will post -0.52 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.watchlistnews.com/investors-purchase-high-volume-of-put-options-on-imperva-impv/1708483.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.